There’s a graph that every longevityresearcher knows. It shows NAD+ levels in human tissue plotted against age. Theline goes in one direction: down. By age 50, most people have lost 40-50% ofthe NAD+ they had at 20. By 70, the decline can exceed 60%.
This isn’t just an interesting data point.NAD+ decline is now considered one of the fundamental drivers of aging — a rootcause, not merely a symptom. When NAD+ falls below critical thresholds, thecellular machinery that keeps you healthy starts to malfunction. Understandingthis decline — and taking action to address it — is one of the most impactfulthings you can do for your long-term health.
NAD+ decline isn’t caused by a single factor.It’s the result of multiple converging biological processes.
Increased CD38 activity is one of the primaryculprits. CD38 is an enzyme that consumes NAD+ as part of the immune response.As chronic, low-grade inflammation (sometimes called “inflammaging”) increaseswith age, CD38 activity rises, burning through NAD+ stores faster than they canbe replenished.
DNA damage accumulation also plays a majorrole. Every day, your cells sustain tens of thousands of DNA damage events fromnormal metabolic processes, environmental toxins, and UV radiation. The enzymePARP1, which repairs this damage, requires NAD+ as fuel. As damage accumulateswith age, PARP1 consumes more and more NAD+.
Decreased NAD+ biosynthesis compounds theproblem. The enzymes responsible for producing NAD+ from dietary precursors(like NAMPT) become less efficient with age, reducing the body’s ability toreplenish its stores.
The result is a supply-and-demand crisis:demand for NAD+ increases while supply decreases. This drives a cascade ofdownstream effects that manifest as the symptoms and diseases of aging.
When NAD+ levels fall, multiple criticalsystems are affected simultaneously.
Mitochondrial dysfunction is perhaps the mostimmediately noticeable. Mitochondria — your cells’ power plants — depend onNAD+ for energy production. Low NAD+ means less ATP, which you experience as fatigue,reduced stamina, and slower recovery. Over time, mitochondrial dysfunctioncontributes to virtually every age-related disease.
Impaired DNA repair leads to genomicinstability, accumulating mutations, and cellular senescence — the state wherecells stop dividing but don’t die, instead secreting inflammatory compoundsthat damage surrounding tissue.
Sirtuin deactivation occurs because thesirtuin family of proteins can’t function without NAD+. When sirtuins gooffline, the body loses critical regulation of inflammation, metabolism, stressresponse, and circadian rhythm. Research in animal models has shown thatrestoring sirtuin activity through NAD+ repletion can reverse many aspects ofaging.
Neurodegeneration is also linked to NAD+ decline.Brain cells are among the most metabolically active in the body and areparticularly vulnerable to NAD+ depletion. Declining NAD+ in the brain isassociated with cognitive decline, reduced neuroplasticity, and increased riskof neurodegenerative conditions.
The encouraging news is that NAD+ levels arenot fixed. Research has demonstrated that NAD+ repletion through directsupplementation or precursor administration can meaningfully raise NAD+ levelsin human tissues.
However, not all approaches are equallyeffective. Over-the-counter NAD+ precursors like NMN and NR can raise NAD+modestly, but their oral bioavailability is limited and the quality ofcommercial supplements varies widely.
Clinical-grade NAD+ therapy — the kind offeredthrough Luvo’s longevity program — provides several advantages. Luvo’s NAD+injection delivers the molecule directly, bypassing digestive losses formaximum impact. NAD+ oral liquid drops use sublingual delivery for improvedabsorption over standard capsules. NAD+ nasal spray offers rapid mucosalabsorption with potential cognitive advantages.
The choice of delivery method, dosing, andfrequency should be tailored to your individual needs — which is exactly whatLuvo’s clinical team provides.
The decline in NAD+ begins in your 30s andaccelerates through your 40s and 50s. Many longevity experts argue thatproactive NAD+ repletion should begin before symptoms of decline become obvious— in other words, before you feel old, not after.
That said, patients at any adult age canbenefit from NAD+ therapy. If you’re experiencing unexplained fatigue,cognitive fog, slow recovery, or a general sense that your body isn’tperforming the way it used to, declining NAD+ may be a contributing factor.
Luvo’s longevity program can help you assessyour needs and build a NAD+ protocol — whether standalone or as part of acomprehensive longevity approach including Sermorelin and Vitamin B12/MIC.Explore our NAD+ options: injection, oral liquid drops, and nasal spray.
NAD+ therapy has emerged as one of the mostpromising interventions in longevity medicine. But once you’ve decided topursue NAD+ therapy, a practical question arises: how should you take it?
Luvo’s longevity program is one of the fewthat offers three distinct NAD+ delivery options — injection, oral liquiddrops, and nasal spray. Each method has different absorption characteristics,convenience factors, and potential advantages. This guide helps you understandthe differences so you can make an informed choice with your Luvo provider.
NAD+ injection delivers the molecule directlyinto your body via subcutaneous or intramuscular injection, bypassing thedigestive system entirely.
Bioavailability is the standout advantage.Because the NAD+ enters your system without passing through the GI tract orliver first-pass metabolism, a much higher percentage of the administered dosereaches your cells. This makes injection the most efficient delivery method interms of dose-to-effect ratio.
Injections are typically administered on a setschedule — often 2-3 times per week depending on your protocol. Many patientsreport the most pronounced and rapid effects with injectable NAD+, includingnoticeable energy improvements and mental clarity within the first week.
The trade-off is that injections requirecomfort with self-administration (though the needles are very small) and properstorage of the medication. For patients who want the highest-impact NAD+delivery and don’t mind the injection process, this is often the preferredchoice.
Explore Luvo’s NAD+ injection option for fulldetails.
NAD+ oral liquid drops are designed forsublingual administration — placed under the tongue and held for 30-60 secondsbefore swallowing. This route allows a portion of the NAD+ to absorb directlythrough the mucous membranes of the mouth into the bloodstream.
Sublingual absorption partially bypassesdigestive degradation, offering better bioavailability than standard oralcapsules or tablets. The liquid formulation is also easier to dose preciselyand absorb than solid supplements.
The primary advantage is convenience and easeof use. There are no needles, no special storage requirements beyond basicguidelines, and the drops can be taken anywhere as part of a daily routine.This makes oral drops particularly appealing for patients who are new to NAD+therapy or prefer a gentler introduction.
Bioavailability is moderate compared toinjection — some NAD+ is still lost to digestive processes. However, consistentdaily dosing can build and maintain meaningful NAD+ levels over time.
Learn more about Luvo’s NAD+ oral liquiddrops.
NAD+ nasal spray delivers the molecule throughthe nasal mucosa — the thin, highly vascularized tissue lining the nasalpassages. This route offers rapid absorption into the bloodstream and a uniquepotential advantage: proximity to the brain.
The nasal cavity is separated from the brainby the cribriform plate, a thin bony structure that allows some moleculesdelivered intranasally to reach the central nervous system more directly thanother delivery routes. While research on intranasal NAD+ specifically is stilldeveloping, the theoretical advantage for cognitive benefits — includingimproved focus, mental clarity, and neuroprotection — makes this an excitingoption for patients whose primary concern is brain health.
Nasal spray is also needle-free and quick toadminister, making it a practical choice for daily use. Most patients find itstraightforward after the first few uses.
The bioavailability of nasal delivery fallsbetween injection and oral drops, offering a solid middle ground for patientswho want better absorption than oral but prefer to avoid injections.
Explore Luvo’s NAD+ nasal spray for moredetails.
The right choice depends on your priorities.
If maximum potency and fastest results areyour priority, NAD+ injection is the clear leader. It delivers the most NAD+per dose and produces the most pronounced effects. Choose this if you’recomfortable with needles and want the strongest intervention.
If convenience and simplicity matter most,NAD+ oral liquid drops fit seamlessly into any daily routine. They’re theeasiest to start with and require no special technique. Choose this if you wanta low-friction daily habit.
If cognitive function and brain health areyour focus, NAD+ nasal spray offers a compelling combination of ease andpotential neuro-specific benefits. Choose this if mental clarity, focus, andbrain longevity are top priorities.
If you want comprehensive coverage, somepatients in Luvo’s longevity program use a combination of delivery methods —for example, injections twice weekly supplemented by daily nasal spray. Yourprovider can help design a protocol that maximizes benefit for your specificgoals.
Visit Luvo’s longevity program to discuss youroptions with a provider, or explore each option individually: NAD+ injection,NAD+ oral liquid drops, and NAD+ nasal spray.
If you read most longevity articles, they focuson a single mechanism: take this one supplement, boost this one molecule, fixthis one pathway. But aging doesn’t work that way. It’s a convergence ofmultiple interconnected declines happening simultaneously — and addressing onlyone while ignoring the others produces limited results.
Three of the most well-documented andconsequential age-related declines are NAD+ depletion, growth hormonereduction, and methylation dysfunction. Individually, each drives significantaspects of aging. Together, they create a self-reinforcing cycle thataccelerates the entire process.
Luvo’s longevity program is specificallydesigned to address all three — and the science explains why this integratedapproach matters.
NAD+ sits at the center of cellular energymetabolism. As the essential coenzyme for mitochondrial ATP production, NAD+determines how efficiently your cells convert nutrients into usable energy.When NAD+ declines, mitochondria become dysfunctional — they produce less energyand more reactive oxygen species (free radicals), creating oxidative stressthat damages cellular components.
But NAD+’s role extends beyond energy. It’sthe required substrate for sirtuins, the family of proteins that regulate DNArepair, inflammation, and metabolic homeostasis. It’s consumed by PARP enzymesduring DNA repair. And it participates in over 500 enzymatic reactions thatmaintain cellular function.
The decline of NAD+ with age is a masterswitch that affects virtually every other cellular process. This is why NAD+therapy — whether through Luvo’s NAD+ injection, oral drops, or nasal spray —forms one pillar of the longevity program.
Growth hormone (GH) and its downstreammediator, IGF-1, are the body’s primary signals for tissue repair,regeneration, and maintenance. GH stimulates protein synthesis in muscles,collagen production in skin and connective tissue, bone mineralization, andimmune cell production.
The decline in GH production with age — termedsomatopause — directly contributes to muscle wasting (sarcopenia), increasedvisceral fat, reduced bone density, slower wound healing, and declining immunecompetence. These aren’t cosmetic issues; they’re functional declines thatpredict frailty, falls, metabolic disease, and reduced quality of life.
Sermorelin addresses somatopause by restoringthe pituitary’s natural GH output. But here’s the critical connection: growthhormone’s tissue-building effects require adequate cellular energy. Withoutsufficient NAD+ to power the metabolic machinery, the cells receiving GH’srepair signals may not have the energy to execute them. This is why Sermorelinand NAD+ therapy work better together than either does alone.
Methylation is a biochemical process where amethyl group (CH3) is transferred from one molecule to another. This seeminglysimple reaction is involved in DNA repair and gene expression regulation,neurotransmitter synthesis (serotonin, dopamine, melatonin), detoxification ofenvironmental toxins and metabolic waste, immune system regulation, andhistamine metabolism.
The methylation cycle requires adequate levelsof B12, folate, methionine, and choline — exactly the components in Luvo’sB12/MIC injection. When methylation declines with age or due to nutrientinsufficiency, the consequences cascade across multiple systems.
Perhaps most importantly, methylation is themechanism behind epigenetic regulation — the system that determines which genesare turned on or off. Disrupted methylation leads to aberrant gene expressionpatterns that are increasingly recognized as a hallmark of biological aging.Researchers now use DNA methylation patterns as “epigenetic clocks” to measurebiological age.
These three systems don’t operate inisolation. They’re deeply interconnected.
NAD+ fuels the sirtuins that regulateepigenetic patterns (methylation). Growth hormone stimulates tissue repair thatrequires NAD+-powered energy. Methylation recycles the precursors needed forboth NAD+ biosynthesis and growth hormone signaling. B12 and methionine supportthe salvage pathways that regenerate NAD+ from its metabolites.
When you address only one pillar, the othersbecome rate-limiting. Boosting NAD+ without supporting growth hormone leavesthe repair signals inadequate. Stimulating growth hormone without supportingcellular energy leaves cells unable to respond. Supporting methylation withoutadequate NAD+ limits the epigenetic maintenance that methylation is supposed toprovide.
This is the fundamental insight behind Luvo’smulti-therapy longevity program. Sermorelin, NAD+ therapy, and Vitamin B12/MICaren’t three random treatments bundled together — they’re three interventionstargeting the three pillars of cellular aging in a way that creates genuinesynergy.
Explore Luvo’s complete longevity program tounderstand how these therapies work together for your health.
The world of longevity peptides can feel likea maze. Sermorelin, Ipamorelin, CJC-1295, Tesamorelin, BPC-157 — the list ofpeptides marketed for anti-aging, recovery, and performance seems to growmonthly. For patients interested in growth hormone optimization, understandingthe differences between these peptides is essential for making safe, informedchoices.
Among the options, Sermorelin has emerged asthe gold standard for clinically supervised growth hormone optimization — andthere are compelling reasons why Luvo’s longevity program features it as a coretherapy.
Sermorelin is a GHRH (growth hormone-releasinghormone) analog with the longest clinical track record of any growth hormonepeptide. It was FDA-approved in 1997 for the treatment of growth hormonedeficiency, giving it decades of safety data that newer peptides simply don’thave.
The key distinction is how Sermorelin works.As a GHRH analog, it stimulates the pituitary gland to produce and releasegrowth hormone through the body’s own regulatory mechanisms. This means growthhormone release remains pulsatile (released in natural bursts rather thancontinuous elevation), the hypothalamic-pituitary axis retains feedbackcontrol, and the risk of supraphysiological growth hormone levels is minimized.
Other peptides work through differentmechanisms. Ipamorelin and GHRP-6 are growth hormone secretagogues thatstimulate growth hormone release through the ghrelin receptor pathway. CJC-1295is a long-acting GHRH analog that provides extended growth hormone stimulation.While these peptides can be effective, they have less long-term safety data andsome carry additional side effect profiles, including increased hunger (ghrelinpathway peptides) and cortisol or prolactin elevation.
For physicians prescribing growth hormoneoptimization as part of a longevity protocol, safety is the primaryconsideration. These are therapies intended for long-term use in otherwisehealthy adults — the risk-benefit calculation is different from treating anacute disease.
Sermorelin’s safety profile is well-established.Common side effects are mild and typically limited to injection-site reactionssuch as redness or swelling, transient headaches during the initial treatmentperiod, and flushing or dizziness that usually resolves with continued use.
Serious adverse events are rare in theclinical literature. Because Sermorelin works through the body’s naturalregulatory pathways, the risk of growth hormone excess — the primary concernwith direct HGH injection — is inherently limited. Your pituitary gland hasbuilt-in mechanisms to prevent overproduction, and Sermorelin respects thosemechanisms.
This safety profile is why Luvo’s medical teamchose Sermorelin over newer, less-studied peptide alternatives. In longevitymedicine, the goal is sustained benefit over years or decades — and thatrequires a therapy you can trust for the long haul.
Some clinics offer peptide “stacks” —combinations of multiple growth hormone peptides administered together forsynergistic effect. While there’s theoretical logic behind some combinations,the clinical evidence supporting specific stacks is limited, and combiningmultiple peptides increases the complexity and unpredictability of treatment.
Luvo’s approach is different. Rather thanstacking multiple growth hormone peptides, our longevity program combinesSermorelin with complementary therapies that work on entirely differentpathways: NAD+ for cellular energy and DNA repair, and Vitamin B12/MIC formetabolic optimization. This creates true synergy without the risks of peptidepolypharmacy.
The result is a protocol where each componenthas a clear, distinct role — and where the safety profile of each therapy iswell-understood individually.
If you’re interested in growth hormoneoptimization, Sermorelin through Luvo’s longevity program offers the mostclinically responsible path. Our providers will evaluate your health history,discuss your goals, and determine whether Sermorelin is appropriate for you.
Because Sermorelin’s effects develop gradually— optimal results typically emerge over 3-6 months of consistent use — it’s atherapy that rewards patience and commitment. The improvements in sleep,energy, body composition, and recovery are real, but they build over timerather than appearing overnight.
Learn more about Luvo’s Sermorelin therapy, orexplore how it fits into the complete longevity program alongside NAD+ therapyand Vitamin B12/MIC.